Fluconazolo

Diflucan, Elazor, Flukimex e altri

Bibliografia - Quali fonti bibliografiche per Fluconazolo?

1. Adverse Drug Reaction Bulletin, 2012


2. Aleck K.A., Bartley D.L., Am. J. Med. Genet., 1997, 72 (3), 253.


3. Allison E.J. Jr. et al., Eur. J. Emerg. Med., 2002, 9 (2), 175.


4. Ahonen J. et al., Eur. J. Clin. Pharmacol., 1997, 51 (5), 415.


5. Ahonen J. et al., Acta Anaesthesiol. Scand., 1999, 43 (5), 509.


6. Amsden G.W. et al., Clin. Drug Invest., 2000, 20 (2), 135.


7. Apseloff G. et al., J. Clin. Pharmacol., 1991, 31, 358.


8. Babalola C.P. et al., J. Clin. Pharm. Ther., 2009, 34 (6), 677.


9. Beecker J., Colantonio S., CMAJ, 2012, 184 (6), 675.


10. Benedix F. et al., Acta Derm. Venereol., 2008, 88 (5), 491.


11. Black D.J. et al., Drug Metab. Dispos., 1996, 24 (4), 422.


12. Blum R.A. et al., Pharmacotherapy, 1999, 19 (4 Pt 2), 79S.


13. Cadle R.M. et al., The Annals of Pharmacotherapy, 1994, 28 (2, 191.


14. Calonghi G., Gabbi E., Inf. sui Farmaci, 1989, XIII (3), 255.


15. Canafax D.M. et al., Transplantation, 1991, 51, 1014.


16. Cato A et al., Drug Metab. Dispos., 1997, 25 (9), 1104.


17. Cheitlin M.D. et al., J. Am. Coll. Cardiol., 1999, 33 (1), 273.


18. Cob M.N. et al., Clin. Pharmacol. Ther., 1998, 63 (6), 655.


19. Cooper K.J. et al., Eur. J. Clin. Pharmacol., 2002, 58 (8), 527.


20. Crussell-Porter L.L., Arch. Intern. Med., 1993, 153, 102.


21. Damle B. et al., Antimicrob. Agents Chemother., 2011, 55 (11), 5172.


22. Dastghaib L. et al., J. Dermatolog. Treat., 2005, 16 (1), 43.


23. Debruyne D., Clin. Pharmacokinet., 1997, 33 (1), 52.


24. Dismukes W.E., Ann. Intern. Med., 1988, 109 (3), 177.


25. Dugal H.S., Gen. Hosp. Psychiatry, 2003, 25 (4), 297.


26. EMEA, Diflucan - Article 30 referral - Assessment Report, 2 febbraio disponibile online http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Diflucan/human_referral_000278.jsp&mid=WC0b01ac05805c516f


27. EMEA, Diflucan - Article 30 referral - Annex III, 2 febbraio dispnibile online http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Diflucan/human_referral_000278.jsp&mid=WC0b01ac05805c516f.


28. Ernst E.J. et al., Diagn. Microbiol. Infect. Dis., 1998, 32 (3), 205.


29. Foster K.W. et al., J. Am. Acad. Dermatol., 2005, 53 (5), 798.


30. Gondo H. et al., Bone Marrow Transplant., 2000, 26 (11), 1255.


31. Grant S.M., Clissold S.P., Drugs, 1990, 39, 877.


32. Greenblatt D.J. et al., Clin. Pharmacol. Ther., 2006, 79 (1), 125.


33. Hallberg P. et al., Eur. J. Clin. Pharmacol., 2006, 62 (6), 491.


34. Harnicar S. et al., J. Oncol. Pharm. Pract., 2009, 15 (3), 175.


35. Hazin R. et al., J. Natl. Med. Assoc., 2008, 100 (4), 444.


36. Hilbert J. et al., Obstet. Gynecol., 2001, 98 (2), 218.


37. Hitchcock C.A. et al., Antimicrob. Agents Chemother., 1993, Sep. 37, 1962.


38. Hynninen V.V. et al., Antimicrob. Agents Chemother., 2006, 50 (6), 1967.


39. Holmes D. et al., Case Rep. Oncol. Med., 2012, 2012, 313057.


40. Honig P.K. et al., Clin. Pharmacol. Ther., 1993, 53 (6), 630.


41. JAMA ed. it., 1990, 2, 740.


42. Jordan M.K. et al., Antimicrob. Agents Chemother., 2000, 44 (8), 2170.


43. Kahri J. et al., Eur. J. Clin. Pharmacol., 2005, 60 (12), 905.


44. Kakuda T.N. et al., Clin. Pharmacokinet., 2011, 50 (1), 25.


45. Kantola T. et al., Eur. J. Clin. Pharmacol., 2000, 56 (3), 225.


46. Kaukonen K.M. et al., Eur. J. Clin. Pharmacol., 1998, 53 (6), 445.


47. Kim C.Y. et al., Ann. Dermatol., 2011, 23 Suppl. 1, S1.


48. Konishi H. et al., Eur. J. Clin. Pharmacol., 1994, 46 (4), 309.


49. Koks C.H. et al., Br. J. Clin. Pharmacol., 2001, 51 (6), 631.


50. Lane M.A. et al., J. Clin. Pharm. Ther., 2012, 37 (2), 157.


51. Lee B. et al., Pediatr. Infect. Dis. J., 1992, 11 (12), 1062.


52. Lazar J.D., Rev. Infect. Dis., 1990, 12 (Suppl. 3), S327.


53. Lopez-Rangel E. et al., Birth Defects Res. A Clin. Mol. Teratol., 2005, 73 (11), 919


54. Marino M.R., Vachharajani N.N., Clin. Pharmacokinet., 2001, 40 (8), 605.


55. Marr K.A. et al., Blood, 2004, 103 (4), 1557.


56. Mazziotti F. et al., Minerva Ginecol., 1992, 44, 653.


57. Med. Lett., ed. it., 1994, 7, 27.


58. Michalets E.L., Williams C.R., Clin. Pharmacokinet., 2000, 39 (1), 49.


59. Mihara A. et al., Eur. J. Clin. Pharmacol., 2008, 64 (1), 89.


60. Mitchell A.S., Holland J.T., BMJ, 1989, 268 (6683), 1315


61. Mootha V.V. et al., 2002, 120 (1), 94.


62. Nair D.R., Morris H.H., Ann. Pharmacother., 1999, 33 (7-8), 790.


63. Nicolau D.P. et al., Ann. Pharmacother., 1995, 29 (10), 994.


64. Newberry D.L. et al., Clin. Infect. Dis., 1997, 24 (2), 270.


65. Noorgard M. et al., J. Antimicrob. Chemother., 2008, 62 (1), 172.


66. Palkama V.J. et al., Anest. Analg., 1998, 87 (1), 190.


67. Pea F. et al., Ann. Pharmacother., 2008, 42 (11), 1711.


68. Pursley T.J. et al., Clin. Infect. Dis., 1996, 22 (2), 336.


69. Rees T. Phillips R., Intern. J. Gynecol. Obstet., 1992, Suppl. 37, 33.


70. Robinson R.F. et al., Ann. Pharmacother., 2000, 34 (12), 1406.


71. Saari T.I. et al., Eur. J. Clin. Pharmacol., 2008, 64 (1), 25.


72. Sahai J. et al., J. Infect. Dis., 1994, 169 (5), 1103.


73. Sadaba B. et al., Transplant. Proc., 2004, 36 (10), 3226.


74. Santos J.R. et al., Antimicrob. Agents Chemother., 2012, 56 (5), 2553.


75. Scheda prodotto Diflucan, 2009.


76. Schwartz E.L. et al., Biochem. Pharmacol., 1995, 50 (7), 923.


77. Schelleman H. et al., Clin. Pharmacol. Ther., 2008, 84 (5), 581.


78. Shaukat A. et al., Ann. Pharmacother., 2003, 37 (7-8), 1032.


79. Sinai J. et al., J. Infect. Dis., 1994, 169, 1103.


80. Sobel J.D., Int. J. Gyaecol. Obstet., 1992, 37 Suppl.1, 17.


81. St Clair K., Maguire J.D., Int. J. STD AIDS, 2012, 23 (5), 371.


82. Stergiopoulou T. et al., J. Antimicrob. Chemother., 2009, 63 (2), 343.


83. Tarumi Y. et al., J. Pain Symptom Manage., 2002, 23 (2), 148.


84. Tavallaee M., Rad M.M., J. Med. Case Rep., 2009, 6 (3), 7368.


85. Terrell C.L., Mayo Clin. Proc., 1999, 74 (1), 78.


86. Teusink A.C. et al., Pediatr. Hematol. Oncol., 2012, 29 (1), 62.


87. Thi L. et al., Consult. Pharm., 2009, 24 (3), 227.


88. Tholakanahalli V.N. et al., Ann. Pharmacother., 2001, 35, 432.


89. Tiao G.M. et al., Clin. Transplant., 1999, 13 (1 Pt 1), 62.


90. Tirkkonen T. et al., J. Intern. Med., 2010, 268 (4), 359.


91. Trapnell C.B. et al., Ann. Intern. Med., 1996, 124 (6), 573.


92. Tucker R.M. et al., Clin. Infect. Dis., 1992, 14 (1), 165.


93. Upton A. et al., Biol. Blood Marrow Tramsplant., 2007, 13 (7), 760.


94. Vahre A. et al., Br. J. Clin. Pharmacol., 1996, 41 (4), 319.


95. Vahre A. et al., Br. J. Clin. Pharmacol., 1996a, 42 (4), 465.


96. Van Heusden A.M. et al., Acta Obst. Gynecol. Scan., 1990, 69, 417.


97. Vanier K.L. et al., J. Pediatr. Hematol. Oncol., 2003, 25 (5), 403.


98. Venkatakrishnan K. et al., Clin. Pharmacokinet., 2000, 38 (2), 111.


99. Walling H.W., SwickB.L., J. Drug Dermatol., 2010, 9 (8), 1025.


100. Wassmann S. et al., Ann. Intern. Med., 1999, 131 (10), 797.


101. Yeates R.A., Br. J. Clin. Pharmac., 1994, 38, 77.


102. Yu D.T. et al., Pharmacoepidemiol. Drug Saf., 2005, 14 (11), 755.


103. Ziegler C., Soltz-Szots J., Sex Transm. Dis., 1994, 21 Suppl., 177.